Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Inventiva S.A. ADR
(NQ:
IVA
)
2.730
+0.010 (+0.37%)
Streaming Delayed Price
Updated: 3:59 PM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Inventiva S.A. ADR
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 14, 2024
Via
Benzinga
Why Is Fatty-Liver Drug Developer Inventiva Stock Trading Higher On Monday?
October 14, 2024
Inventiva secures €94.1M in financing, potentially reaching €348M, to fund the Phase 3 NATiV3 trial for lanifibranor in NASH. Leadership changes include new chairman and director appointments.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 14, 2024
Via
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
October 14, 2024
Via
Benzinga
Where Inventiva Stands With Analysts
June 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 26, 2024
Via
Benzinga
Gold Falls Over 1%; HilleVax Shares Plunge
July 08, 2024
Via
Benzinga
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 08, 2024
Via
Benzinga
Dow Turns Lower; Myomo Shares Jump
July 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
July 08, 2024
Via
Benzinga
Why Is Inventiva's Stock Trading Higher on Monday?
May 13, 2024
Inventiva's Lanifibranor improves cardiometabolic health in MASH/NASH patients. It lowers fasting glucose, reduces cardiovascular risk, and increases adiponectin levels. Weight gain correlates with...
Via
Benzinga
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
February 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 16, 2024
Via
Benzinga
Why Is Liver Disease-Focused Inventiva Stock Trading Lower Today?
February 16, 2024
Inventiva announces a voluntary pause in NATiV3 Phase 3 trial of lanifibranor for NASH due to a treatment-related SUSAR. Screening and randomization halted temporarily.
Via
Benzinga
Why The Trade Desk Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
February 16, 2024
Shares of The Trade Desk, Inc. (NASDAQ: TTD) shares rose sharply in today’s pre-market trading after the company reported mixed fourth-quarter financial results<
Via
Benzinga
Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 16, 2024
Shares of DoorDash, Inc. (NASDAQ: DASH) fell sharply in today’s session as the company reported mixed financial results for its fourth quarter.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Via
Benzinga
Yelp Reports Q4 Results, Joins Roku, Dropbox And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 16, 2024
U.S. stock futures were mixed this morning, with the Nasdaq futures trading higher by around 100 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 16, 2024
Via
Benzinga
Earnings Scheduled For September 28, 2023
September 28, 2023
Companies Reporting Before The Bell • CarMax (NYSE:KMX) is projected to report quarterly earnings at $0.78 per share on revenue of $7.03 billion.
Via
Benzinga
Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
September 21, 2023
Thursday, CymaBay Therapeutics Inc (NASDAQ: CBAY) initiated the AFFIRM Phase 3b/4 confirmatory study to evaluate the effect of seladelpar on clinical outcomes in patients with compensated cirrhosis due...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 20, 2023
Via
Benzinga
Why MicroVision Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket
June 15, 2023
Gainers EdtechX Holdings Acquisition Corp. II (NASDAQ: EDTX) shares gained 139.8% to $26.54 in pre-market trading.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 14, 2023
Via
Benzinga
Dow Falls Over 100 Points; US Producer Prices Drop In May
June 14, 2023
U.S. stocks traded mixed this morning, with Dow Jones dropping over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.32% to 34,101.52 while the NASDAQ rose 0.16%...
Via
Benzinga
PLUG Stock Alert: Plug Power Announces New Avina Deal
June 14, 2023
Plug Power (PLUG) stock is on the move Wednesday after the EV charging company announced a deal with Avina Clean Hydrogen.
Via
InvestorPlace
Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 14, 2023
Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.